Literature DB >> 35246768

In vitro leishmanicidal activity of two cholesterol derivatives.

Angélica Patricia Isaac-Márquez1, Claudio Manuel Lezama-Dávila2.   

Abstract

We evaluated the leishmanicidal activity of commercially available 5α-cholest-7-en-3β-ol [5α-chol], (+)-4-cholesten-3-one [(+)-4-chol] and the equimolar mixture of the two of them in promastigotes and amastigotes of two different strains of Leishmania mexicana (LCL) and (DCL). The leishmanicidal effectiveness of these sterols was determined by promastigote growth-kinetic experiments and promastigote viability using the propidium iodide staining procedure. The proliferation test was performed using the CFSE (5-Carboxyfluorescein N-succinimidyl ester) staining of parasites at different time points. To determine the leishmanicidal effectiveness of these sterols in amastigotes, we evaluated parasite killing inside of macrophages at different time points. The trypan blue exclusion test was used to determine cytotoxicity of sterols in uninfected macrophages. We included in all experiments a control group of parasites treated with 2% DMSO (Dimethyl Sulfoxide) and another one treated with the reference drug sodium stibogluconate (Sb). Our results showed that the equimolar mixture at 2000 times lower concentration presented similar leishmanicidal activity as Sb. This mixture was similarly effective at 100 times lower concentration than individual sterols tested separately indicating the existence of a synergistic effect against LCL and DCL parasites. The therapeutic index of the equimolar mixture was 10,000-16,000 times higher than the one recorded by Sb and was not cytotoxic to macrophages. Therefore, the equimolar mixture of 5α-Chol and (+)-4-chol may represent a potential alternative for the treatment of cutaneous leishmaniasis.
© 2022. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  ( +)-4-cholesten-3-one; 5α-cholest-7-en-3β-ol; Equimolar mixture of sterols; L. mexicana; Leishmanicidal activity; Sterols

Mesh:

Substances:

Year:  2022        PMID: 35246768     DOI: 10.1007/s11274-022-03248-x

Source DB:  PubMed          Journal:  World J Microbiol Biotechnol        ISSN: 0959-3993            Impact factor:   3.312


  20 in total

Review 1.  Leishmaniasis chemotherapy--challenges and opportunities.

Authors:  S L Croft; P Olliaro
Journal:  Clin Microbiol Infect       Date:  2011-10       Impact factor: 8.067

2.  Oxysterols: Synthesis and anti-leishmanial activities.

Authors:  Pranab Ghosh; Ashim Ghosh; Amitava Mandal; Sirin Salma Sultana; Somaditya Dey; Chiranjib Pal
Journal:  Steroids       Date:  2015-12-29       Impact factor: 2.668

3.  Synthesis of oxysterols and nitrogenous sterols with antileishmanial and trypanocidal activities.

Authors:  Marc-Antoine Bazin; Philippe M Loiseau; Christian Bories; Yves Letourneux; Sylvain Rault; Laïla El Kihel
Journal:  Eur J Med Chem       Date:  2006-09-01       Impact factor: 6.514

4.  Fluorescent dyes for cell viability: an application on prefixed conditions.

Authors:  C Foglieni; C Meoni; A M Davalli
Journal:  Histochem Cell Biol       Date:  2001-03       Impact factor: 4.304

5.  Decanethiol functionalized silver nanoparticles are new powerful leishmanicidals in vitro.

Authors:  A P Isaac-Márquez; P Talamás-Rohana; N Galindo-Sevilla; S E Gaitan-Puch; N A Díaz-Díaz; G A Hernández-Ballina; C M Lezama-Dávila
Journal:  World J Microbiol Biotechnol       Date:  2018-02-19       Impact factor: 3.312

6.  Cytokine regulation of female-macrophage resistance to Leishmania mexicana parasites. Role of IL-12p70.

Authors:  Angélica P Isaac-Márquez; Claudio M Lezama-Dávila
Journal:  Parasite Immunol       Date:  2020-01-11       Impact factor: 2.280

7.  Leishmanicidal activity of two naphthoquinones against Leishmania donovani.

Authors:  Claudio Manuel Lezama-Dávila; Angelica Patricia Isaac-Márquez; Govind Kapadia; Katherine Owens; Steve Oghumu; Stephen Beverley; Abhay Rajaninath Satoskar
Journal:  Biol Pharm Bull       Date:  2012       Impact factor: 2.233

8.  Stigmasterol as a potential biomarker for amphotericin B resistance in Leishmania donovani.

Authors:  Ruby Bansal; Shib Sankar Sen; Rohini Muthuswami; Rentala Madhubala
Journal:  J Antimicrob Chemother       Date:  2020-04-01       Impact factor: 5.790

Review 9.  Advances in Development of New Treatment for Leishmaniasis.

Authors:  Juliana Perrone Bezerra de Menezes; Carlos Eduardo Sampaio Guedes; Antônio Luis de Oliveira Almeida Petersen; Deborah Bittencourt Mothé Fraga; Patrícia Sampaio Tavares Veras
Journal:  Biomed Res Int       Date:  2015-05-11       Impact factor: 3.411

Review 10.  Leishmaniasis in humans: drug or vaccine therapy?

Authors:  Masoud Ghorbani; Ramin Farhoudi
Journal:  Drug Des Devel Ther       Date:  2017-12-22       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.